Tjernberg Agneta, Markova Natalia, Griffiths William J, Hallén Dan
Department of Lead Discovery, Biovitrum AB, Stockholm, Sweden.
J Biomol Screen. 2006 Mar;11(2):131-7. doi: 10.1177/1087057105284218. Epub 2006 Feb 20.
DMSO is the standard solvent for preparing stock solutions of compounds for drug discovery. The assay concentration of DMSO is normally 0.1% to 5% (v/v) or 14 to 715 mM. Thus, DMSO is often one of the principal additives in assay buffers. This standardization of stock solutions does not eliminate possible pitfalls associated with the effects of the DMSO-containing solutions on individual proteins. In this article, the authors want to emphasize the importance of detailed studies of these effects in the early stages of drug discovery. Two protein systems, the extracellular soluble domain of the human growth hormone receptor (hGHbp) and the phosphatase domain of PFKFB1 (BPase), were used for the study on effects of DMSO on protein stability, protein aggregation, and binding of drug compounds. The study revealed significant differences in the proteins' behavior in the presence and absence of low amounts of DMSO. The addition of DMSO resulted in destabilization of the proteins investigated and also changed the apparent binding property of 1 protein. The authors have also shown that low DMSO concentrations influence the ionization process in electrospray ionization mass spectrometry (ESI-MS).
二甲基亚砜(DMSO)是药物研发中制备化合物储备溶液的标准溶剂。DMSO在分析中的浓度通常为0.1%至5%(v/v)或14至715 mM。因此,DMSO常常是分析缓冲液中的主要添加剂之一。储备溶液的这种标准化并不能消除与含DMSO溶液对单个蛋白质的影响相关的潜在问题。在本文中,作者想强调在药物研发早期详细研究这些影响的重要性。使用了两种蛋白质系统,即人生长激素受体(hGHbp)的细胞外可溶性结构域和磷酸果糖激酶2-1(PFKFB1)的磷酸酶结构域(BPase)来研究DMSO对蛋白质稳定性、蛋白质聚集以及药物化合物结合的影响。该研究揭示了在存在和不存在少量DMSO的情况下蛋白质行为的显著差异。DMSO的添加导致所研究蛋白质的不稳定,并且还改变了一种蛋白质的表观结合特性。作者还表明,低浓度的DMSO会影响电喷雾电离质谱(ESI-MS)中的电离过程。